2. Academic Validation
  3. A Novel FXR-Targeted DUBTAC and Its Applications in Cholestasis Therapy

A Novel FXR-Targeted DUBTAC and Its Applications in Cholestasis Therapy

  • J Med Chem. 2026 Apr 9;69(7):7642-7662. doi: 10.1021/acs.jmedchem.5c02905.
Ming Cui 1 2,  Bin Tang 1 2,  Tingting Yao 1 2,  Wenbin Shao 3,  Qiuling Zheng 3,  Huiyong Sun 1 4,  Haiping Hao 1 2,  Hong Wang 1 2,  Xiaowei Xu 1 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210000, P. R. China.
  • 2 Jiangsu Provincial Key Laboratory of Targetome and Innovative Drugs, Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, Nanjing 210000, P. R. China.
  • 3 Department of Pharmaceutical Analysis, College of Pharmacy, China Pharmaceutical University, Nanjing 210009, P.R. China.
  • 4 Department of Pharmaceutical Chemistry, College of Pharmacy, China Pharmaceutical University, Nanjing 210000, P. R. China.
PMID: 41860185 DOI: 10.1021/acs.jmedchem.5c02905
Abstract

Farnesoid X receptor (FXR) is critical for cholestatic liver disease therapy, but FXR agonists often show compromised efficacy due to FXR protein degradation under pathological conditions. Here, we report the first discovery of potent FXR DUBTAC stabilizer D11 as a candidate for cholestasis. We designed and synthesized 31 novel compounds by tethering canonical FXR ligands (e.g., OCA, CDCA) to the OTUB1 ligand EN523 via diverse linkers. D11 elevated FXR protein levels in HepG2 cells in a dose- and time-dependent manner, and its action required a functional ubiquitin-proteasome system. It also significantly increased the hepatic FXR protein level in mice with α-naphthylisothiocyanate (ANIT)-induced cholestasis liver injury. Importantly, D11 demonstrated excellent hepatoprotective efficacy against cholestasis with a reliable safety profile. Thus, D11 emerges as a promising lead compound for FXR-targeted cholestasis therapy, paving a new avenue for drug development by stabilizing, rather than merely activating the receptor.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z